Abstract:Oscar Rosenkrantz, 1, 2 Jannik Wheler, 1 Mats Christian Westphal Thrane, 3 Lars Pedersen, 1 Henrik Toft Sørensen 1 1 Department of Clinical Epidemiology and Center for Population Medicine, Aarhus University Hospital and Aarhus University, Aarhus, Denmark; 2 Department of Anaesthesia, Centre of Head and Orthopaedics, Rigshospitalet, Copenhagen, Denmark; 3 Danish Health Data Authority, Copenhagen, Denmark Correspondence: Oscar Rosenkrantz, Department of Clinical Epidemiology, Aarhus University Hospital and Aarhus University, Olof Palmes Allé 43, 45, DK, Aarhus N, 8200, Denmark, Tel +45 87 16 72 12, Email Background: The Danish National Hospital Medication Register (DHMR), one of the first nationwide in-hospital medication registries in the world, contains detailed information on medication administration and dispensing. Objective: To provide an overview of the information recorded in the DHMR and to highlight its strengths and limitations as a pharmacoepidemiological research tool. Methods: We reviewed the registry ́s geographic and clinical specialty coverage and medications recorded according to the main groups of the Anatomical Therapeutic Chemical classification system. Results: From May 2018 through December 2023, the DHMR recorded data on more than 1.9 million unique patients from all approximately 50 public hospitals and associated hospital outpatient clinics, totaling 105.3 million recordings of hospital medication use. The registry records detailed data on the indication for medication, medication type, pharmaceutical form, dosage, and administration time, collected through electronic medical record systems. Although the data quality has not yet been evaluated in a scientific context, some potential limitations are known. These include regional differences in the data collection and a lack of data from certain clinical specialties. Due to its recent establishment in 2018, the registered number of patients treated may still be limited for some rarely used medications. Conclusion: The DHMR is an important new resource for research in Denmark. Combined with the Danish National Prescription Registry, which covers all community pharmacies, it offers access to accurate data on medication exposure in the Danish population. Users should be aware of potential issues with lack of information before 2018. Keywords: pharmacoepidemiology, hospital medication system, pharmacotherapy, data source, drug databases, registry data, Denmark Pharmacoepidemiology is the study of medication use and its effects in large populations. 1 A key objective of pharmacoepidemiological research is post-approval detection of adverse effects not identified in phase 3 trials, achieved by examining medication use in populations treated in routine clinical practice. 2 Many medication withdrawals based on phase 4 studies — including early examples such as diethylstilbestrol; 3 publicly well-known cases, such as thalidomide 4 and rofecoxib; 5 and, more recently, ranitidine 6 — have led to increased demand for evidence-based drug safety beyond traditional passive surveillance. 7 The increased digitization of healthcare has enabled the creation of medical databases containing vast amounts of data over long periods. 8 These extensive databases have provided possibilities for conducting low-cost, large-scale, population-based pharmacoepidemiological research on rare and long-term adverse effects, which were impossible to accomplish decades ago, but few databases include detailed data on medication use from patients treated in hospitals. 9,10 The databases recording in-hospital medication use do not usually capture all segments of a target population because registration in the databases, except in a few cases, 11–13 is often predicated on qualifying factors such as age; employment or insurance status; or hospital health network affiliation or specialty. 14 Denmark has established many high-quality health registries over decades. 8 One is the Danish National Prescription Registry, 15 which holds detailed information on prescriptions dispensed at all Danish community pharmacies and is widely used in pharmacoepidemiology. However, the registry does not record data on in-hospital medication use. The recently established Danish National Hospital Medication Register (DHMR) provides detailed data on medication used within all public hospitals in Denmark. This advancement enhances opportunities for research by allowing for in-depth analysis of medication use in the community and during hospital stays. Several hospital medications -Abstract Truncated-

Identifying high‐risk medications and error types in Danish patient safety database using disproportionality analysis

A characterization and disproportionality analysis of medication error related adverse events reported to the FAERS database

Analysis of a Pharmacist-Led Adverse Drug Event Management Model for Pharmacovigilance in an Academic Medical Center Hospital in China

Disproportionality Analysis and Characterisation of Medication Errors in EudraVigilance: Exploring Findings on Sexes and Age Groups

An Empirical Approach to Explore the Relationship Between Measures of Disproportionate Reporting and Relative Risks from Analytical Studies

Discovering clinical drug-drug interactions with known pharmacokinetics mechanisms using spontaneous reporting systems and electronic health records

Identification of Novel Signals Associated with US-FDA Approved Drugs (2013) Using Disproportionality Analysis

Prospective risk assessments of patient safety events related to drug shortages in hospitals: Three actor-level perspectives

Medication errors related to high-alert medications in a paediatric university hospital - a cross-sectional study analysing error reporting system data

The Danish National Hospital Medication Register: A Resource for Pharmacoepidemiology

A Retrospective Observational Study of Adverse Drug Reactions (ADR) Reported to ADR Monitoring Centre from 2010 to 2020

Analysis of Medication Errors Reported by Community Pharmacists in the Republic of Korea: A Cross-Sectional Study

Safety Signals Using Proportional Reporting Ratios from Company and Regulatory Authority Databases

Paediatric medication incident reporting: a multicentre comparison study of medication errors identified at audit, detected by staff and reported to an incident system

Detectability of Medication Errors With a STOPP/START-Based Medication Review in Older People Prior to a Potentially Preventable Drug-Related Hospital Admission

Medication Safety in Mental Health Hospitals: A Mixed-Methods Analysis of Incidents Reported to the National Reporting and Learning System

Statistical Signal Detection Algorithm in Safety Data: A Proprietary Method Compared to Industry Standard Methods

Analysis of the nature and contributory factors of medication safety incidents following hospital discharge using National Reporting and Learning System (NRLS) data from England and Wales: a multi-method study

Potentially inappropriate medications (PIMs): frequency and extent of GP-related variation in PIMs: a register-based cohort study

Medication adverse events in the ambulatory setting: A mixed-methods analysis

Medication‐related incidents in acute care hospitals among different age groups: An analysis of national patient safety report data